相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 库存:
416
- 英文名:
Recombinant Human Tumor Necrosis Factor alpha
- 保质期:
长期
- 供应商:
北京百奥莱博科技有限公司
- 保存条件:
冻干蛋白置于-20℃以下可长期保存,室温
- 规格:
10μg|50μg|500μg|1mg
特别提示:包括重组人肿瘤坏死因子α(N端His标签)在内,本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!
产品名称:重组人肿瘤坏死因子α(N端His标签)
英文名称:Recombinant Human Tumor Necrosis Factor alpha
产品货号:JN0468
产品规格:10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备而成,目的基因编码的Gly57-Leu233在N端含有His标签。
TNF-alpha质量控制:>95%(还原性SDS-PAGE)
TNF-alpha制剂:冻干品
TNF-alpha保存:
冻干蛋白置于-20℃以下可长期保存,室温条件下可稳定保存3周。
复溶蛋白溶液可在4~7℃保存2~7天,可分装后置于-20℃保存三个月。
TNF-alpha复溶:
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后,请根据用量分装冻存,避免反复冻融。
关于TNF-alpha:
Tumor Necrosis Factor-α (TNF-α) is secreted by macrophages, monocytes, neutrophils, T-cells, and NK-cells following stimulation by bacterial LPS. Cells expressing CD4 secrete TNF-α while cells that express CD8 secrete little or no TNF-α. Synthesis of TNF-α can be induced by many different stimuli including interferons, IL2, and GM-CSF. The clinical use of the potent anti-tumor activity of TNF-α has been limited by the proinflammatory side effects such as fever, dose-limiting hypotension, hepatotoxicity, intravascular thrombosis, and hemorrhage. Designing clinically applicable TNF-α mutants with low systemic toxicity has been of intense pharmacological interest. Human TNF-α that binds to murine TNF-R55 but not murine TNF-R7, exhibits retained anti-tumor activity and reduced systemic toxicity in mice compared with murine TNF-α, which binds to both murine TNF receptors. Based on these results, many TNF-α mutants that selectively bind to TNF-R55 have been designed. These mutants displayed cytotoxic activities on tumor cell lines in vitro and have exhibited lower systemic toxicity in vivo. Recombinant Human TNF-α High Active Mutant differs from the wild-type by amino acid subsitution of amino acids 1-7 with Arg8, Lys9, Arg10 and Phe157. This mutant form has been shown to have increased activity with less inflammatory side effects in vivo.
除了重组人肿瘤坏死因子α(N端His标签),,我公司还供应以下相关产品:
| 货号 | 名称 | 规格 |
| JN0223 | 重组人NT3(神经营养素3)(含前导肽) | 10μg|50μg|500μg|1mg |
| JN0259 | 重组人CTGF(CCN2)(结缔组织生长因子) | 10μg|50μg|500μg|1mg |
| JN0331 | 重组小鼠趋化因子CCL2(MCP-1) | 10μg|50μg|500μg|1mg |
| JN0402 | 重组人白介素22受体α2(带Fc标签) | 10μg|50μg|500μg|1mg |
| JN0481 | 重组小鼠TNFRSF13B | 10μg|50μg|500μg|1mg |
| JN1919 | 重组人分子伴侣辅因子(热休克蛋白70羧基末端相互作用蛋白)(CHIP)(STUB1) | 10μg|50μg|500μg|1mg |
| JN0587 | 重组人Nectin-1(PVRL1) | 10μg|50μg|500μg|1mg |
| JN0632 | 重组人钙连蛋白(Calnexin) | 10μg|50μg|500μg|1mg |
| JN0664 | 重组人THSD1(含凝血酶敏感蛋白1结构域的蛋白1) | 10μg|50μg|500μg|1mg |
| JN0757 | 重组人乳铁传递蛋白(LTF)(乳运铁蛋白) | 10μg|50μg|500μg|1mg |
| JN1026 | 重组人GCDH(线粒体戊二酰辅酶A脱氢酶) | 10μg|50μg|500μg|1mg |
| JN1059 | 重组人三结构域蛋白(三重基序蛋白5)(TRIM5) | 10μg|50μg|500μg|1mg |
| JN1172 | 重组人CALCB(降钙素基因相关肽2) | 10μg|50μg|500μg|1mg |
| JN1343 | 重组人过氧化物还原蛋白4(Peroxiredoxin 4) | 10μg|50μg|500μg|1mg |
| JN1499 | 重组人间皮蛋白(Mesothelin) | 10μg|50μg|500μg|1mg |
| JN1527 | 重组人PDCD1(PD-1)(CD279 mutant) | 10μg|50μg|500μg|1mg |
| JN1569 | 重组小鼠CTLA-4(CD152)(C端带His标签) | 10μg|50μg|500μg|1mg |
| JN1575 | 重组大鼠B7-2(CD86) | 10μg|50μg|500μg|1mg |
| JN1588 | 重组人Importinβ1(KPNB1)(核转运受体蛋白)(输入蛋白β1) | 10μg|50μg|500μg|1mg |
| JN1659 | 重组MAP | 10μg|50μg|500μg|1mg |
| JN1833 | 重组人CD73(5-Nucleotidase) | 10μg|50μg|500μg|1mg |
| ZN1572 | 人BMP4重组蛋白 | 100ng |
| ZN1573 | 人BMP5重组蛋白 | 100ng |
| ZN1599 | 人CDC37重组蛋白 | 100ng |
| ZN1667 | 人Laminin重组蛋白 | 100ng |
| ZN1707 | 人SCF-SF9重组蛋白 | 100ng |
| ZN1718 | 人TIE-2重组蛋白 | 100ng |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
重组人肿瘤坏死因子α(N端His标签)
¥1880 - 2880









